Jorge Cortell, Kanteron Systems’ CEO, has been included in the HIMSS Future50 International: top 50 Healthcare IT leaders, in the category of Innovation.
Jorge Cortell, Kanteron Systems’ CEO, presented “Data integration and processing of Infectious Disease events” solution to manage the Dengue epidemic at the BioInvestment Asia forum held at EH 102 - 104, BITEC, in Bangkok.
NASA Space Technology Mission Directorate’s iTech initiative is a yearlong effort to find innovative ideas (through 3 annual Cycles) that address challenges and will fill gaps in five critical areas identified by NASA as having a potential impact on future exploration. In the focus area of Healthcare, Kanteron Systems’ Precision Medicine Software has been selected as a Top healthcare software of the year, top 3 healthcare technology of the year, and top 25 overall technology of Cycle II.
NASA iTech searches for and identifies advancements in technologies that are solving problems on Earth and have the potential to address existing challenges to enable NASA missions. NASA judges selected 10 innovations based on criteria including technical viability, likely impact on future space exploration, benefits to humanity and commercialization potential. One of those innovations selected by NASA is Kanteron Systems’ Precision Medicine Software.
According to the metrics and methodology of the Financial Times 1000: Europe’s Fastest Growing Companies Kanteron Systems currently meets the criteria to be in the top 100 of Europe’s Fastest Growing Companies. Note: final inclusion or not in the next edition of the list will be decided by the editorial team of the FT during the next publication period (September-December 2019).
Kanteron Systems presents its latest R&D development in NGS and CNV analysis application, Panelmaps, at the European Society of Human Genetics (ESHG19) annual meeting in Gothenburg (Sweden).
Kanteron Systems CEO, participated today as member of a round table in the Medical Data and AI conference which was held at the Foundation for the Promotion of Health and Biomedical Research of the Valencian Region (FISABIO), in Spain.
